Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

How accurate are stock forecasts?

Stock forecasts are based on technical and fundamental analysis but should not be considered as guaranteed predictions. Past performance does not guarantee future results.

How do I analyze RNAZ stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate RNAZ investment potential.

What is RNAZ stock price today?

Get real-time RNAZ stock price, historical data, and price charts on Financhill. Track RNAZ performance with our advanced analysis tools.

Is RNAZ a good investment?

Evaluate RNAZ investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy RNAZ stock?

To buy RNAZ stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of RNAZ?

View detailed market capitalization data and company valuation metrics for RNAZ on our comprehensive analysis page.

What is the P/E ratio of RNAZ?

Use our fundamental analysis tools to view RNAZ P/E ratio and compare valuation metrics with industry peers.

What are RNAZ earnings?

View RNAZ earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

TransCode Therapeutics, Inc. Stock Predictions

This AI Layer Just Raised Its Share Price

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Sell

RNAZ
TransCode Therapeutics, Inc.

Last Price:

$8.59

Seasonality Move:

-30.19%

7 Day Trial

ALL ACCESS PASS

$ 7

Missed $0.81? RAD Intel Now Open at $0.85/Share

TransCode Therapeutics, Inc. Stock Forecast

Over the next 52 weeks, TransCode Therapeutics, Inc. has on average historically fallen by 88.2% based on the past 4 years of stock performance.
TransCode Therapeutics, Inc. has fallen lower in 4 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
Is TransCode Therapeutics, Inc. Stock Undervalued?

The current TransCode Therapeutics, Inc. [RNAZ] share price is $8.64. The Score for RNAZ is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
RNAZ is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will TransCode Therapeutics, Inc. Stock Go Up Next Year?

Over the next 52 weeks, TransCode Therapeutics, Inc. has on average historically fallen by 88.2% based on the past 4 years of stock performance.

TransCode Therapeutics, Inc. Stock Rating

Sell

TransCode Therapeutics, Inc. (RNAZ) is a Sell

Is TransCode Therapeutics, Inc. overpriced?

TransCode Therapeutics, Inc. has fallen lower in 4 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%

TransCode Therapeutics, Inc. Stock Price History

Is RNAZ stock going to rise?

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RNAZ is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:

NASDAQ

Country:

United States

Industry:

Biotechnology

Sector:

Health Care

Type:

stock

Website:

transcodetherapeutics.com

52-Week Data

52-Week High:

468.44

52-Week Low:

6.15

Prediction Charts

Market Cap:

7.2M

Price in USD:

8.64

Volume:

3.3K

Beta:

1.53

Technical Analysis

SMA50:

11.02

SMA100:

10.90

SMA200:

16.87

52-Wk Change:

-96.84%

Stock Predictions

Is TransCode Therapeutics, Inc. stock public?

Yes, TransCode Therapeutics, Inc. is a publicly traded company.
What is the TransCode Therapeutics, Inc. stock quote today?

The TransCode Therapeutics, Inc. stock price is 8.64 USD today.
How to buy TransCode Therapeutics, Inc. stock online?

You can buy TransCode Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date	Opening	Closing	Minimum	Maximum
Nov-14	8.57	9.24	9.24	8.57
Nov-17	9.00	9.41	9.43	8.75
Nov-18	9.20	9.03	9.39	8.99
Nov-19	9.01	8.99	9.42	8.90
Nov-20	8.55	8.56	9.26	8.51
Nov-21	8.48	8.64	8.80	8.48
Nov-24	8.73	9.05	9.16	8.73
Nov-25	8.90	9.19	9.21	8.90
Nov-26	9.22	9.22	9.41	9.20
Nov-28	9.30	9.29	9.30	9.29
Dec-1	9.29	9.29	9.29	9.29
Dec-2	8.91	8.95	9.00	8.51
Dec-3	8.77	8.41	8.77	8.20
Dec-4	8.48	8.64	8.78	8.45

TransCode Therapeutics, Inc. Earnings

TransCode Therapeutics, Inc. Earnings Report: Per Share TransCode Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

TransCode Therapeutics, Inc. Forecast Revenue Growth

TransCode Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for TransCode Therapeutics, Inc. and historical quarterly revenue growth:

Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $131.65 per share, and an increase next year of $1.31 per share.

* TransCode Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.